The state also filed an application with the court for reimbursement of litigation expenses. Johnson & Johnson also is appealing the judge's order, maintaining the award should be reduced by $355 million to offset the pretrial settlements reached with other drugmakers. The company also maintains the judge misapplied the state's public nuisance laws in reaching his decision.
Cleveland County District Judge Thad Balkman in August ruled Johnson & Johnson and its subsidiaries helped fuel the opioid crisis with an aggressive and misleading marketing campaign that overstated how effective the drugs were for treating chronic pain and understated the risk of addiction.
The judge initially ordered the company to pay $572 million, but later reduced that amount after acknowledging he made a miscalculation.